miR-146a and miR-146b are highly expressed in the metastatic human breast cancer cell line MDA-MB-231 and negatively regulate NF-κB activity by targeting the 3’ UTRs of IRAK1 and TRAF6. The gene discussed is NFKB1; the disease is breast carcinoma.